These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10389595)

  • 1. T cell numbers relate to bone involvement in Gaucher disease.
    Lacerda L; Arosa FA; Lacerda R; Cabeda J; Porto G; Amaral O; Fortuna A; Pinto R; Oliveira P; McLaren CE; Sá Miranda C; de Sousa M
    Blood Cells Mol Dis; 1999 Apr; 25(2):130-8. PubMed ID: 10389595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.
    Fairley C; Zimran A; Phillips M; Cizmarik M; Yee J; Weinreb N; Packman S
    J Inherit Metab Dis; 2008 Dec; 31(6):738-44. PubMed ID: 18979180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement.
    Lebel E; Elstein D; Peleg A; Reinus C; Zimran A; Amir G
    Am J Clin Pathol; 2013 Jul; 140(1):91-6. PubMed ID: 23765538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.
    Sibille A; Eng CM; Kim SJ; Pastores G; Grabowski GA
    Am J Hum Genet; 1993 Jun; 52(6):1094-101. PubMed ID: 8503443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience.
    Grigorescu Sido P; Drugan C; Cret V; Al-Kzouz C; Denes C; Coldea C; Zimmermann A
    J Inherit Metab Dis; 2007 Oct; 30(5):783-9. PubMed ID: 17703370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tartrate-resistant acid phosphatase staining of monocytes in Gaucher disease.
    Troy K; Cuttner J; Reilly M; Grabowski G; Desnick R
    Am J Hematol; 1985 Jul; 19(3):237-44. PubMed ID: 4014224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
    Choy FY
    Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.
    Taddei TH; Kacena KA; Yang M; Yang R; Malhotra A; Boxer M; Aleck KA; Rennert G; Pastores GM; Mistry PK
    Am J Hematol; 2009 Apr; 84(4):208-14. PubMed ID: 19260119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of osteoclasts from type 1 Gaucher patients and correlation with clinical and genetic features of disease.
    Reed MC; Bauernfreund Y; Cunningham N; Beaton B; Mehta AB; Hughes DA
    Gene; 2018 Dec; 678():196-206. PubMed ID: 30099023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone events and evolution of biologic markers in Gaucher disease before and during treatment.
    Stirnemann J; Belmatoug N; Vincent C; Fain O; Fantin B; Mentré F
    Arthritis Res Ther; 2010; 12(4):R156. PubMed ID: 20696071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sphingolipids on osteoblast and osteoclast activity in Gaucher disease.
    Reed MC; Schiffer C; Heales S; Mehta AB; Hughes DA
    Mol Genet Metab; 2018 Aug; 124(4):278-286. PubMed ID: 29934064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3).
    Weinreb NJ; Finegold DN; Feingold E; Zeng Z; Rosenbloom BE; Shankar SP; Amato D
    Orphanet J Rare Dis; 2015 May; 10():64. PubMed ID: 25994334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
    Giraldo P; Pocoví M; Pérez-Calvo J; Rubio-Félix D; Giralt M
    Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity in patients with Gaucher disease and the N370S/V394L genotype.
    Elstein D; Scott CR; Zeigler M; Abrahamov A; Zimran A
    Genet Test; 2005; 9(1):26-9. PubMed ID: 15857183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes.
    Orenstein M; Barbouth D; Bodamer OA; Weinreb NJ
    Orphanet J Rare Dis; 2014 Mar; 9():45. PubMed ID: 24685312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I Gaucher disease (GDI) in three siblings: enzyme replacement treatment (ERT) required.
    Gucev ZS; Tasic V; Pop-Jordanova N; Kirovski I; Stomnaroska O; Martinova M; Jancevska A; Kremensky I; Sinigerska I
    Prilozi; 2009 Jul; 30(1):233-40. PubMed ID: 19736544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease.
    Drugan C; Jebeleanu G; Grigorescu-Sido P; Caillaud C; Craciun AM
    Blood Cells Mol Dis; 2002; 28(1):13-20. PubMed ID: 11814307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease.
    Reed M; Baker RJ; Mehta AB; Hughes DA
    Blood Cells Mol Dis; 2013 Oct; 51(3):185-94. PubMed ID: 23707505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype variations in Gaucher disease.
    Mistry P; Germain DP
    Rev Med Interne; 2006 Mar; 27 Suppl 1():S3-10. PubMed ID: 16644399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.